IP Verse

Fred Hutchinson Cancer Research Center opposition analysis

COMPANY ANALYSIS

Latest patents of Fred Hutchinson Cancer Research Center opposed by its competitors

Patent:
EP3688157
Grant Date:
Apr 27, 2022
Title:
High Efficiency Targeted In Situ Genome-Wide Profiling
Oppositions:
1
Patent:
EP3636778
Grant Date:
Jan 12, 2022
Title:
Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)
Oppositions:
2
Patent:
EP3247808
Grant Date:
May 5, 2021
Title:
Point-Of-Care And/Or Portable Platform For Gene Therapy
Oppositions:
2
Patent:
EP3363901
Grant Date:
Dec 30, 2020
Title:
Compositions And Methods For Accurately Identifying Mutations
Oppositions:
3
Patent:
EP2689010
Grant Date:
Nov 18, 2020
Title:
Method And Compositions For Cellular Immunotherapy
Oppositions:
1
Patent:
EP2884999
Grant Date:
Nov 4, 2020
Title:
Method And Compositions For Cellular Immunotherapy
Oppositions:
1
Patent:
EP3192880
Grant Date:
Oct 9, 2019
Title:
Nucleic Acid Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)
Oppositions:
2
Patent:
EP2814959
Grant Date:
Jan 17, 2018
Title:
Compositions And Methods For Accurately Identifying Mutations
Oppositions:
1

Competitors of Fred Hutchinson Cancer Research Center

STRAWMAN LIMITED

JAMES POOLE LIMITED

KONIG SZYNKA TILMANN VON RENESSE

Want to track Fred Hutchinson Cancer Research Center?

Feel free to send us a message here and we will get back to you